Company: ADPT
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103752
Chunk: 19

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 19
---
 Responsibilities Michelle Griffin, Michael Pellini, MD and Peter Neupert serve on the audit committee, which is currently chaired by Ms. Griffin. The audit committee met seven times during 2024. Our board of directors has determined that each member of the audit committee during 2024 was and is “independent” as that term is defined in Nasdaq rules and has sufficient knowledge in financial and auditing matters to serve on the audit committee. In addition, our board of directors has determined that Ms. Griffin, Dr. Pellini, and Mr. Neupert each meet the heightened independence requirements for audit committee members required under Section 10A of the Exchange Act and related SEC and Nasdaq rules. Following the 2025 Annual Meeting, Katey Owen, PhD will replace Dr. Pellini on the audit committee. Dr. Owen also meets the heightened independence requirements for audit committee members required under Section 10A of the Exchange Act and related SEC and Nasdaq rules. Our board of directors has determined that each member of the audit committee is an “audit committee financial expert,” as defined in Item 407(d)(5)(ii) of Regulation S-K.The audit committee’s responsibilities include:

| • |     | Appointing, approving the compensation of and assessing the independence of our independent registered public accounting firm. |

| • |     | Pre-approving audit and permissible non-audit services, and the terms of such services, to be provided by our independent registered public accounting firm. |

| • |     | Reviewing the overall audit plan with our independent registered public accounting firm and members of management responsible for preparing our financial statements. |

| • |     | Reviewing and discussing with management and our independent registered public accounting firm our annual and quarterly financial statements and related disclosures, as well as critical accounting policies and practices used by us. |

13

| • |     | Coordinating the oversight and reviewing the adequacy of our internal control over financial reporting. |

| • |     | Establishing policies and procedures for the receipt and retention of accounting-related complaints and concerns. |

| • |     | Recommending, based upon the audit committee’s review and discussions with management and our independent registered public accounting firm, whether our audited financial statements should be included in our Annual Report on Form 10-K. |

| • |     | Monitoring the integrity of our financial statements and our compliance with legal and regulatory requirements as they relate to our financial statements and accounting matters. |

| • |     | Preparing the audit committee report required